<p>Doximity（紐約證券交易所代碼：DOCS - 獲取免費報告）在週四發佈的報告中，Needham &amp; Company LLC 將其目標價格從 55.00 美元下調至 27.00 美元，Benzinga 報道。該券商目前對該股票給予 “買入” 評級。Needham &amp; Company LLC 的目標價格暗示該公司當前價格有 14.82% 的潛在上漲空間。</p>
<ul>
<li>Doximity 是醫療社區的 Facebook 和 LinkedIn</li>
</ul>
<p>其他幾家股票研究分析師也對 DOCS 發佈了報告。BTIG Research 在週四將 Doximity 的評級從 “買入” 下調至 “中性”。摩根大通將 Doximity 的目標價格從 40.00 美元下調至 33.00 美元，並在 2 月 20 日的報告中對該公司給予 “中性” 評級。加拿大皇家銀行在 3 月 9 日的報告中重申了 “跑贏大盤” 評級，並對 Doximity 的股票設定了 44.00 美元的目標價格。Canaccord Genuity Group 在 2 月 9 日的報告中對 Doximity 設定了 34.00 美元的目標價格，並給予該股票 “買入” 評級。最後，BMO 資本市場在 2 月 6 日的報告中對 Doximity 設定了 25.00 美元的目標價格。兩位投資分析師對該股票給予了強烈買入評級，九位給予了買入評級，十二位給予了持有評級。根據 MarketBeat.com 的數據，該公司目前的共識評級為 “適度買入”，平均目標價格為 33.60 美元。</p>
<p><strong>閲讀我們關於 DOCS 的最新報告</strong></p>
<h2>Doximity 股價下跌 11.1%</h2>
<ul>
<li>Doximity 是一個被忽視的醫療生態系統 AI 投資</li>
</ul>
<p>Doximity 的股票在週四開盤價為 23.52 美元。該公司的市值為 43.4 億美元，市盈率為 19.60，市盈增長比率為 1.88，貝塔值為 1.36。Doximity 的 52 周低點為 20.55 美元，52 周高點為 76.51 美元。該公司的 50 日移動平均價格為 24.27 美元。</p>
<p>Doximity 宣佈其董事會於 2 月 5 日啓動了一項股票回購計劃，允許公司回購 5 億美元的流通股。該回購授權允許公司通過公開市場購買最多 8% 的股票。股票回購計劃通常表明公司的管理層認為其股票被低估。</p>
<h2>內部買賣</h2>
<ul>
<li>Doximity 股票是一個有趣的醫療投資</li>
</ul>
<p>在其他新聞中，董事 Kira Scherer Wampler 在 5 月 7 日的交易中出售了 9,000 股公司的股票。該股票以平均價格 26.06 美元出售，總交易額為 234,540.00 美元。出售後，該董事直接持有公司 19,839 股，價值約 517,004.34 美元。此次交易使其持股減少了 31.21%。該交易已在向 SEC 提交的文件中披露，SEC 網站可查閲。該交易是在預先安排的 10b5-1 交易計劃下執行的。此外，內部人士 Siddharth Sitaram 在 5 月 11 日的交易中出售了 2,309 股公司的股票。該股票以平均價格 25.77 美元出售，總價值為 59,502.93 美元。出售後，該內部人士持有公司 89,396 股，價值約 2,303,734.92 美元。這代表其持股減少了 2.52%。此次出售的披露可在 SEC 文件中找到。該交易是在預先安排的 10b5-1 交易計劃下執行的。此次出售是為了覆蓋與股權獎勵歸屬相關的税款扣繳義務。在過去 90 天內，內部人士已出售 18,055 股公司股票，價值 456,061 美元。31.30% 的股票目前由公司內部人士持有。</p>
<h2>機構投資者對 Doximity 的看法</h2>
<p>一些對沖基金最近對該公司的持倉進行了調整。先鋒集團在第四季度將其在 Doximity 的持股增加了 4.1%。先鋒集團目前擁有 13,285,485 股公司股票，價值 588,281,000 美元，此前在上個季度增持了 518,916 股。Aubrey Capital Management Ltd 在第三季度購買了 Doximity 的新頭寸，價值約 4,572,000 美元。瑞銀集團在第四季度將其在 Doximity 的持股增加了 26.5%。瑞銀集團目前擁有 680,260 股公司股票，價值 30,122,000 美元，此前在該期間增持了 142,408 股。Blair William &amp; Co. IL 在第三季度將其在 Doximity 的持股增加了 1,990.7%。Blair William &amp; Co. IL 目前擁有 362,740 股公司股票，價值 26,534,000 美元，此前在該期間增持了 345,390 股。最後，William Blair Investment Management LLC 在第三季度將其在 Doximity 的持股增加了 11.7%。William Blair Investment Management LLC 目前擁有 5,829,169 股公司股票，價值 426,404,000 美元，此前在該期間增持了 609,775 股。機構投資者和對沖基金持有該公司 87.19% 的股票。</p>
<h2>影響 Doximity 的主要新聞</h2>
<p>以下是本週影響 Doximity 的主要新聞故事：</p>
<ul>
<li>積極情緒：Doximity 報告調整後每股收益為 0.26 美元，超出分析師較低預期的 0.17 美元，收入同比增長 5.1%，達到 1.4537 億美元，顯示出業務仍在增長。Doximity 財報</li>
<li>中性情緒：公司的高利潤率保持不變，股本回報率為 23.84%，淨利潤率為 37.54%，表明持續的運營效率。2026 財年第四季度財報快照</li>
<li>消極情緒：儘管每股收益超出一個預期，但 Doximity 未能達到更廣泛的 Zacks 共識 0.28 美元，這可能讓尋求更強勁超預期的交易者感到失望。Doximity 落後於第四季度收益預期</li>
<li>消極情緒：對投資者來説，更重要的是，Doximity 2027 財年第一季度的收入指引為 1.51 億至 1.52 億美元，低於 1.532 億美元的共識，2027 財年全年的收入指引為 6.64 億至 6.76 億美元，也低於 6.96 億美元的預期，發出較軟的前景信號。Doximity 2026 財年第四季度電話會議記錄</li>
<li>消極情緒：該股票還因本週早些時候的內部交易而面臨額外的謹慎，儘管這被披露為預先安排的 10b5-1 計劃和與股權歸屬相關的税收扣繳。內部交易披露</li>
</ul>
<h2>關於 Doximity</h2>
<p>(獲取免費報告)</p>
<p>Doximity（股票代碼：DOCS）運營一個數字專業網絡和通訊平台，主要為臨牀醫生設計。公司總部位於舊金山，連接醫生、護士執業者、醫師助理及其他醫療專業人員，提供簡化臨牀溝通、遠程醫療交付和獲取專業特定醫療信息的工具。其平台被定位為一個專業中心，臨牀醫生在此管理工作流程，保持醫學新聞的最新動態，並與同行安全協作。</p>
<p>該公司的產品包括安全消息傳遞和視頻遠程醫療功能，使臨牀醫生能夠在保護患者信息的同時與患者和同事進行諮詢。</p>
<h2>瞭解更多</h2>
<ul>
<li>我們更看好的五隻股票，勝過 Doximity</li>
<li>保持航班正常的飛機維修公司準備騰飛</li>
<li>Oklo 股票可能準備再次大幅上漲</li>
<li>D-Wave 財報看起來疲弱，但投資者可能錯過了這一點</li>
<li>隨着 AI 反饋循環加劇，Nebius 上行空間擴大</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURPQ1M?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURPQ1M"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Doximity 嗎？</h2>
<p>在考慮 Doximity 之前，你會想聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Doximity 並不在名單上。</p>
<p>雖然 Doximity 目前在分析師中獲得中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

DOCS

LGHT

HEAL

<p>Needham & Company LLC 將 Doximity (NYSE:DOCS) 的目標股價從 55.00 美元下調至 27.00 美元，同時維持 “買入” 評級。這表明從當前價格來看，潛在上漲幅度為 14.82%。其他分析師也調整了他們的評級，BTIG Research 將評級下調至 “中性”，摩根大通將目標價下調至 33.00 美元。Doximity 的股票開盤價為 23.52 美元，市值為 43.4 億美元。該公司已啓動 5 億美元的股票回購計劃，表明管理層對股票被低估的信心</p>

<p>Doximity (NYSE:DOCS - Get Free Report) had its price target dropped by analysts at Needham &amp; Company LLC from $55.00 to $27.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has a &#34;buy&#34; rating on the stock. Needham &amp; Company LLC's price objective suggests a potential upside of 14.82% from the company's current price.</p>
<div class="lb-trans"><p>Doximity（紐約證券交易所代碼：DOCS - 獲取免費報告）在週四發佈的報告中，Needham &amp; Company LLC 將其目標價格從 55.00 美元下調至 27.00 美元，Benzinga 報道。該券商目前對該股票給予 “買入” 評級。Needham &amp; Company LLC 的目標價格暗示該公司當前價格有 14.82% 的潛在上漲空間。</p>
</div><ul>
<li>Doximity is the Facebook and LinkedIn of the Medical Community</li>
</ul>
<div class="lb-trans"><ul>
<li>Doximity 是醫療社區的 Facebook 和 LinkedIn</li>
</ul>
</div><p>Several other equities research analysts have also issued reports on DOCS. BTIG Research lowered Doximity from a &#34;buy&#34; rating to a &#34;neutral&#34; rating in a report on Thursday. JPMorgan Chase &amp; Co. reduced their target price on Doximity from $40.00 to $33.00 and set a &#34;neutral&#34; rating for the company in a report on Friday, February 20th. Royal Bank Of Canada restated an &#34;outperform&#34; rating and issued a $44.00 target price on shares of Doximity in a report on Monday, March 9th. Canaccord Genuity Group set a $34.00 price target on Doximity and gave the stock a &#34;buy&#34; rating in a report on Monday, February 9th. Finally, BMO Capital Markets set a $25.00 price target on Doximity in a report on Friday, February 6th. Two investment analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and twelve have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $33.60.</p>
<div class="lb-trans"><p>其他幾家股票研究分析師也對 DOCS 發佈了報告。BTIG Research 在週四將 Doximity 的評級從 “買入” 下調至 “中性”。摩根大通將 Doximity 的目標價格從 40.00 美元下調至 33.00 美元，並在 2 月 20 日的報告中對該公司給予 “中性” 評級。加拿大皇家銀行在 3 月 9 日的報告中重申了 “跑贏大盤” 評級，並對 Doximity 的股票設定了 44.00 美元的目標價格。Canaccord Genuity Group 在 2 月 9 日的報告中對 Doximity 設定了 34.00 美元的目標價格，並給予該股票 “買入” 評級。最後，BMO 資本市場在 2 月 6 日的報告中對 Doximity 設定了 25.00 美元的目標價格。兩位投資分析師對該股票給予了強烈買入評級，九位給予了買入評級，十二位給予了持有評級。根據 MarketBeat.com 的數據，該公司目前的共識評級為 “適度買入”，平均目標價格為 33.60 美元。</p>
</div><p><strong>Read Our Latest Report on DOCS</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 DOCS 的最新報告</strong></p>
</div><h2>Doximity Trading Down 11.1%</h2>
<div class="lb-trans"><h2>Doximity 股價下跌 11.1%</h2>
</div><ul>
<li>Doximity is an Overlooked Medical Ecosystem AI Play</li>
</ul>
<div class="lb-trans"><ul>
<li>Doximity 是一個被忽視的醫療生態系統 AI 投資</li>
</ul>
</div><p>Shares of Doximity stock opened at $23.52 on Thursday. The firm has a market cap of $4.34 billion, a price-to-earnings ratio of 19.60, a price-to-earnings-growth ratio of 1.88 and a beta of 1.36. Doximity has a 52-week low of $20.55 and a 52-week high of $76.51. The firm's 50-day moving average price is $24.27.</p>
<div class="lb-trans"><p>Doximity 的股票在週四開盤價為 23.52 美元。該公司的市值為 43.4 億美元，市盈率為 19.60，市盈增長比率為 1.88，貝塔值為 1.36。Doximity 的 52 周低點為 20.55 美元，52 周高點為 76.51 美元。該公司的 50 日移動平均價格為 24.27 美元。</p>
</div><p>Doximity announced that its board has initiated a share repurchase plan on Thursday, February 5th that permits the company to buyback $500.00 million in outstanding shares. This buyback authorization permits the company to purchase up to 8% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's management believes its stock is undervalued.</p>
<div class="lb-trans"><p>Doximity 宣佈其董事會於 2 月 5 日啓動了一項股票回購計劃，允許公司回購 5 億美元的流通股。該回購授權允許公司通過公開市場購買最多 8% 的股票。股票回購計劃通常表明公司的管理層認為其股票被低估。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>內部買賣</h2>
</div><ul>
<li>Doximity Stock is an Interesting Healthcare Play</li>
</ul>
<div class="lb-trans"><ul>
<li>Doximity 股票是一個有趣的醫療投資</li>
</ul>
</div><p>In other news, Director Kira Scherer Wampler sold 9,000 shares of the business's stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $26.06, for a total transaction of $234,540.00. Following the sale, the director directly owned 19,839 shares in the company, valued at approximately $517,004.34. The trade was a 31.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Siddharth Sitaram sold 2,309 shares of the business's stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $25.77, for a total value of $59,502.93. Following the sale, the insider owned 89,396 shares in the company, valued at approximately $2,303,734.92. This represents a 2.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 18,055 shares of company stock worth $456,061. 31.30% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在其他新聞中，董事 Kira Scherer Wampler 在 5 月 7 日的交易中出售了 9,000 股公司的股票。該股票以平均價格 26.06 美元出售，總交易額為 234,540.00 美元。出售後，該董事直接持有公司 19,839 股，價值約 517,004.34 美元。此次交易使其持股減少了 31.21%。該交易已在向 SEC 提交的文件中披露，SEC 網站可查閲。該交易是在預先安排的 10b5-1 交易計劃下執行的。此外，內部人士 Siddharth Sitaram 在 5 月 11 日的交易中出售了 2,309 股公司的股票。該股票以平均價格 25.77 美元出售，總價值為 59,502.93 美元。出售後，該內部人士持有公司 89,396 股，價值約 2,303,734.92 美元。這代表其持股減少了 2.52%。此次出售的披露可在 SEC 文件中找到。該交易是在預先安排的 10b5-1 交易計劃下執行的。此次出售是為了覆蓋與股權獎勵歸屬相關的税款扣繳義務。在過去 90 天內，內部人士已出售 18,055 股公司股票，價值 456,061 美元。31.30% 的股票目前由公司內部人士持有。</p>
</div><h2>Institutional Investors Weigh In On Doximity</h2>
<div class="lb-trans"><h2>機構投資者對 Doximity 的看法</h2>
</div><p>A number of hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in Doximity by 4.1% in the fourth quarter. Vanguard Group Inc. now owns 13,285,485 shares of the company's stock valued at $588,281,000 after acquiring an additional 518,916 shares during the last quarter. Aubrey Capital Management Ltd bought a new position in Doximity in the third quarter valued at about $4,572,000. UBS Group AG lifted its stake in Doximity by 26.5% in the fourth quarter. UBS Group AG now owns 680,260 shares of the company's stock valued at $30,122,000 after buying an additional 142,408 shares during the period. Blair William &amp; Co. IL lifted its stake in Doximity by 1,990.7% in the third quarter. Blair William &amp; Co. IL now owns 362,740 shares of the company's stock valued at $26,534,000 after buying an additional 345,390 shares during the period. Finally, William Blair Investment Management LLC lifted its stake in Doximity by 11.7% in the third quarter. William Blair Investment Management LLC now owns 5,829,169 shares of the company's stock valued at $426,404,000 after buying an additional 609,775 shares during the period. Institutional investors and hedge funds own 87.19% of the company's stock.</p>
<div class="lb-trans"><p>一些對沖基金最近對該公司的持倉進行了調整。先鋒集團在第四季度將其在 Doximity 的持股增加了 4.1%。先鋒集團目前擁有 13,285,485 股公司股票，價值 588,281,000 美元，此前在上個季度增持了 518,916 股。Aubrey Capital Management Ltd 在第三季度購買了 Doximity 的新頭寸，價值約 4,572,000 美元。瑞銀集團在第四季度將其在 Doximity 的持股增加了 26.5%。瑞銀集團目前擁有 680,260 股公司股票，價值 30,122,000 美元，此前在該期間增持了 142,408 股。Blair William &amp; Co. IL 在第三季度將其在 Doximity 的持股增加了 1,990.7%。Blair William &amp; Co. IL 目前擁有 362,740 股公司股票，價值 26,534,000 美元，此前在該期間增持了 345,390 股。最後，William Blair Investment Management LLC 在第三季度將其在 Doximity 的持股增加了 11.7%。William Blair Investment Management LLC 目前擁有 5,829,169 股公司股票，價值 426,404,000 美元，此前在該期間增持了 609,775 股。機構投資者和對沖基金持有該公司 87.19% 的股票。</p>
</div><h2>Key Headlines Impacting Doximity</h2>
<div class="lb-trans"><h2>影響 Doximity 的主要新聞</h2>
</div><p>Here are the key news stories impacting Doximity this week:</p>
<div class="lb-trans"><p>以下是本週影響 Doximity 的主要新聞故事：</p>
</div><ul>
<li>Positive Sentiment: Doximity reported adjusted earnings of $0.26 per share, beating the lower analyst estimate of $0.17, and revenue rose 5.1% year over year to $145.37 million, showing the business is still growing. Doximity Earnings Report</li>
<li>Neutral Sentiment: The company’s high margin profile remained intact, with a 23.84% return on equity and 37.54% net margin, suggesting continued operational efficiency. Fiscal Q4 Earnings Snapshot</li>
<li>Negative Sentiment: Despite the earnings beat versus one estimate, Doximity missed the broader Zacks consensus of $0.28 per share, which may have disappointed traders looking for a stronger beat. Doximity Lags Q4 Earnings Estimates</li>
<li>Negative Sentiment: More importantly for investors, Doximity’s first-quarter FY2027 revenue guidance of $151 million to $152 million came in below the $153.2 million consensus, and full-year FY2027 revenue guidance of $664 million to $676 million also missed the $696 million estimate, signaling a softer outlook. Doximity Q4 2026 Earnings Call Transcript</li>
<li>Negative Sentiment: The stock also faced added caution from an insider sale earlier in the week, though it was disclosed as part of a pre-arranged 10b5-1 plan and tax withholding related to equity vesting. Insider Trade Disclosure</li>
</ul>
<div class="lb-trans"><ul>
<li>積極情緒：Doximity 報告調整後每股收益為 0.26 美元，超出分析師較低預期的 0.17 美元，收入同比增長 5.1%，達到 1.4537 億美元，顯示出業務仍在增長。Doximity 財報</li>
<li>中性情緒：公司的高利潤率保持不變，股本回報率為 23.84%，淨利潤率為 37.54%，表明持續的運營效率。2026 財年第四季度財報快照</li>
<li>消極情緒：儘管每股收益超出一個預期，但 Doximity 未能達到更廣泛的 Zacks 共識 0.28 美元，這可能讓尋求更強勁超預期的交易者感到失望。Doximity 落後於第四季度收益預期</li>
<li>消極情緒：對投資者來説，更重要的是，Doximity 2027 財年第一季度的收入指引為 1.51 億至 1.52 億美元，低於 1.532 億美元的共識，2027 財年全年的收入指引為 6.64 億至 6.76 億美元，也低於 6.96 億美元的預期，發出較軟的前景信號。Doximity 2026 財年第四季度電話會議記錄</li>
<li>消極情緒：該股票還因本週早些時候的內部交易而面臨額外的謹慎，儘管這被披露為預先安排的 10b5-1 計劃和與股權歸屬相關的税收扣繳。內部交易披露</li>
</ul>
</div><h2>About Doximity</h2>
<div class="lb-trans"><h2>關於 Doximity</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.</p>
<div class="lb-trans"><p>Doximity（股票代碼：DOCS）運營一個數字專業網絡和通訊平台，主要為臨牀醫生設計。公司總部位於舊金山，連接醫生、護士執業者、醫師助理及其他醫療專業人員，提供簡化臨牀溝通、遠程醫療交付和獲取專業特定醫療信息的工具。其平台被定位為一個專業中心，臨牀醫生在此管理工作流程，保持醫學新聞的最新動態，並與同行安全協作。</p>
</div><p>The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.</p>
<div class="lb-trans"><p>該公司的產品包括安全消息傳遞和視頻遠程醫療功能，使臨牀醫生能夠在保護患者信息的同時與患者和同事進行諮詢。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than Doximity</li>
<li>Airplane Maintenance Companies That Keep Flights Moving Are Ready to Soar</li>
<li>Oklo Stock Could Be Ready for Another Massive Run</li>
<li>D-Wave Earnings Looked Weak, But Investors May Be Missing This</li>
<li>Nebius Upside Expands as AI Feedback Loop Intensifies</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，勝過 Doximity</li>
<li>保持航班正常的飛機維修公司準備騰飛</li>
<li>Oklo 股票可能準備再次大幅上漲</li>
<li>D-Wave 財報看起來疲弱，但投資者可能錯過了這一點</li>
<li>隨着 AI 反饋循環加劇，Nebius 上行空間擴大</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPURPQ1M" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=DOCS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Doximity Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Doximity 嗎？</h2>
</div><p>Before you consider Doximity, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Doximity 之前，你會想聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Doximity 並不在名單上。</p>
</div><p>While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Doximity 目前在分析師中獲得中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Doximity (NYSE:DOCS) Given New $27.00 Price Target at Needham & Company LLC

Market Beat

Doximity

Langar Global HealthTech ETF

Global X HealthTech ETF

摩根大通

加拿大皇家銀行

蒙特利爾銀行

瑞銀集團

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Needham & Company LLC 給予 Doximity（NYSE:DOCS）新的 27.00 美元目標價